STAT3 and type 1 diabetes mellitus: The immunological and pathological effects of STAT3 inhibition were further evaluated in a non-obese diabetic (NOD) mouse model.<h4>Results</h4>Single-cell transcriptomic analysis revealed enhanced IL-21/STAT3 signaling activity in CD4<sup>+</sup> T cell populations from children with T1D.